-
公开(公告)号:EP2300040A4
公开(公告)日:2012-06-27
申请号:EP09739821
申请日:2009-04-30
申请人: BETH ISRAEL HOSPITAL
CPC分类号: A61K39/0011 , A61K38/08 , A61K38/10 , A61K45/06
摘要: The present invention features methods and compositions (e.g., immune response stimulating peptides (e.g., ERG or SIM2 peptides), activated immune cells, antigen-presenting cells, and antibodies or antigen-binding fragments thereof) for generating an immune response for the treatment of cancer (e.g., prostate cancer).